Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine and cognitive/physical training for cognitive decline prevention in adults with Down syndrome
2011-001556-11Phase 4Completed
- Sponsor
- IRCCS Fondazione Stella Maris
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fluoxetine in Down syndrome (4 arms), sponsored by IRCCS Fondazione Stella Maris. Primary endpoints: Percent variation of evaluated parameters, Cognitive and functional impairment prevention and 2 more. Started Mar 2012; status: completed.
02
Drugs
fluoxetine
03
Conditions
Down syndrome
Beyond the preview
Go deeper on 2011-001556-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001556-11.